“Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis and Skin of Color”, J of Skin, vol. 9, no. 2, p. s549, Mar. 2025, doi: 10.25251/skin.10.supp.549.